TOBRASONE Trademark

Trademark Overview

On Tuesday, February 22, 2022, a trademark application was filed for TOBRASONE with the United States Patent and Trademark Office. The USPTO has given the TOBRASONE trademark a serial number of 97278997. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, August 8, 2024. This trademark is owned by EYEVANCE PHARMACEUTICALS LLC. The TOBRASONE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for ophthalmological use
tobrasone

General Information

Serial Number97278997
Word MarkTOBRASONE
Filing DateTuesday, February 22, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, August 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements

Goods and ServicesPharmaceutical products for ophthalmological use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHARROW IP, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37205
Party NameEYEVANCE PHARMACEUTICALS LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFort Worth, TX 76102
Party NameEYEVANCE PHARMACEUTICALS LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFort Worth, TX 76102

Trademark Events

Event DateEvent Description
Friday, February 25, 2022NEW APPLICATION ENTERED
Monday, February 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 6, 2022ASSIGNED TO EXAMINER
Tuesday, December 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 9, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 12, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 29, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, September 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 6, 2023SOU EXTENSION 1 FILED
Wednesday, September 6, 2023SOU EXTENSION 1 GRANTED
Friday, September 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 12, 2024SOU EXTENSION 2 GRANTED
Monday, February 12, 2024SOU EXTENSION 2 FILED
Thursday, August 8, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 8, 2024SOU EXTENSION 3 FILED
Thursday, August 8, 2024SOU EXTENSION 3 GRANTED
Tuesday, February 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

tobrasone ophthalmological products pharmaceutical